Amy Conrad

Contatto Relazioni con gli Investitori presso TYRA BIOSCIENCES, INC.

Health Technology

Posizioni attive di Amy Conrad

Società	Posizione	Inizio	Fine
TYRA BIOSCIENCES, INC.	Contatto Relazioni con gli Investitori	-	-
TYRA BIOSCIENCES, INC.	Public Communications Contact	-	-
Juniper Point, Inc.	Amministratore Delegato	-	-

Società	Posizione	Inizio	Fine
REGULUS THERAPEUTICS INC.	Contatto Relazioni con gli Investitori	-	01/01/2016
REGULUS THERAPEUTICS INC.	Public Communications Contact	-	01/01/2016
BIONANO GENOMICS, INC.	Contatto Relazioni con gli Investitori	-	-
Anadys Pharmaceuticals, Inc. Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ.	Contatto Relazioni con gli Investitori	23/08/2011	-
	Public Communications Contact	26/05/2010	-

Distribuzione geografica

Stati Uniti

Posizioni

Investor Relations Contact	4
Public Communications Contact	3
Chief Executive Officer	1

Settori

Health Technology

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Aziende private	2
Anadys Pharmaceuticals, Inc. Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ.	Health Technology
Juniper Point, Inc.

Aziende private

Health Technology

Juniper Point, Inc.